REDEEMER ~ NICOLE C. MULLENS

CHAT GPT RESEARCH ON SV40 VACCINE ADDITIVE

Please summerize the research of Dr Pamela Asa and Dr Robert F Garry from Tulane University and the results of their testing for the Squalene Antibody using the ASA ASSAY TEST

Dr. Pamela Asa and Dr. Robert F. Garry of Tulane University conducted research investigating the presence of anti-squalene antibodies in individuals exhibiting symptoms consistent with Gulf War Syndrome (GWS). Their studies utilized the patented Anti-Squalene Antibody Assay (ASA Assay) to detect these antibodies in human serum.

Key Findings:
1. Association with Gulf War Syndrome:
• In a 2000 study, the researchers found that 95% of ill Gulf War veterans and 100% of non-deployed personnel with GWS symptoms tested positive for anti-squalene antibodies. In contrast, none of the healthy deployed veterans had detectable levels of these antibodies.
2. Link to Anthrax Vaccine:
• Further research in 2002 indicated that the presence of anti-squalene antibodies was associated with specific lots of the anthrax vaccine administered during the Department of Defense’s Anthrax Vaccine Immunization Program (AVIP) initiated in 1997. These vaccine lots were found to contain trace amounts of squalene. The study showed that 47% of individuals who received these specific lots developed anti-squalene antibodies, whereas none of the recipients of other lots did.
3. Patent and Validation:
• The ASA Assay developed by Drs. Asa and Garry was patented in April 2001 (U.S. Patent No. 6,214,566) and is licensed to Autoimmune Technologies, LLC. The assay’s validity was further supported when U.S. Army researchers replicated the findings, confirming the existence of anti-squalene antibodies.

Implications:

The research suggests a potential link between squalene-containing vaccine adjuvants and the development of Gulf War Syndrome. The ASA Assay provides a diagnostic tool for detecting anti-squalene antibodies, which may aid in identifying individuals affected by GWS. However, the use of squalene in vaccines and its association with adverse effects remains a topic of debate, and further studies are necessary to fully understand the implications.

If you require more detailed information or access to the full studies, please let me know, and I can assist you further.